| Literature DB >> 28054008 |
Nicola Luigi Bragazzi1, Guglielmo Dini2, Alessandra Toletone3, Francesco Brigo4, Paolo Durando5.
Abstract
This article reports data concerning silicosis-related web-activities using Google Trends (GT) capturing the Internet behavior in the USA for the period 2004-2010. GT-generated data were then compared with the most recent available epidemiological data of silicosis mortality obtained from the Centers for Disease Control and Prevention for the same study period. Statistically significant correlations with epidemiological data of silicosis (r=0.805, p-value <0.05) and other related web searches were found. The temporal trend well correlated with the epidemiological data, as well as the geospatial distribution of the web-activities with the geographic epidemiology of silicosis.Entities:
Keywords: Infodemiology and infoveillance; Internet; Occupational medicine and hygiene; Web 2.0; Work-related diseases
Year: 2016 PMID: 28054008 PMCID: PMC5198853 DOI: 10.1016/j.dib.2016.11.021
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Google Trends-generated heat-map showing the regional interest for silicosis in the USA. In particular, it can be noticed that silicosis-related web searches are concentrated in some counties (namely, California, Texas, New York, Pennsylvania, and Virginia).
Pearson׳s correlation between Google Trends-based data and epidemiological data in the study period 2004–2010.
| Female | Correlation coefficient | −0.145 | −0.144 |
| Significance level P | 0.7562 | 0.7588 | |
| Male | Correlation coefficient | ||
| Significance level | |||
| Correlation coefficient | 0.713 | 0.696 | |
| Significance level | 0.0720 | 0.0825 | |
| Female | Correlation coefficient | 0.010 | −0.001 |
| Significance level | 0.9832 | 0.9980 | |
| Male | Correlation coefficient | ||
| Significance level | |||
| Correlation coefficient | |||
| Significance level | |||
| Female | Correlation coefficient | ||
| Significance level | |||
| Male | Correlation coefficient | ||
| Significance level | |||
| Correlation coefficient | −0.135 | −0.162 | |
| Significance level | 0.7731 | 0.7286 | |
| Female | Correlation coefficient | −0.292 | −0.254 |
| Significance level | 0.5249 | 0.5833 | |
| Male | Correlation coefficient | −0.019 | −0.055 |
| Significance level | 0.9676 | 0.9074 | |
| Female | Correlation coefficient | −0.015 | −0.007 |
| Significance level | 0.9751 | 0.9876 | |
| Male | Correlation coefficient | ||
| Significance level | |||
| Female | Correlation coefficient | −0.155 | −0.149 |
| Significance Level P | 0.7396 | 0.7507 | |
| Male | Correlation coefficient | ||
| Significance level | |||
| Female | Correlation coefficient | −0.292 | −0.254 |
| Significance level | 0.5249 | 0.5833 | |
| Male | Correlation coefficient | 0.030 | 0.004 |
| Significance level | 0.9490 | 0.9939 | |
| Correlation coefficient | |||
| Significance level | |||
| age 15–24 | Correlation coefficient | −0.070 | −0.018 |
| Significance level | 0.8813 | 0.9695 | |
| age 25–34 | Correlation coefficient | −0.657 | −0.656 |
| Significance level | 0.1091 | 0.1092 | |
| age 35–44 | Correlation coefficient | 0.501 | 0.533 |
| Significance level | 0.2520 | 0.2179 | |
| age 45–54 | Correlation coefficient | 0.308 | 0.278 |
| Significance Level P | 0.5017 | 0.5466 | |
| age 55–64 | Correlation coefficient | 0.457 | 0.468 |
| Significance level | 0.3031 | 0.2898 | |
| age 65–74 | Correlation coefficient | 0.619 | 0.622 |
| Significance level | 0.1379 | 0.1357 | |
| age 75–84 | Correlation coefficient | 0.701 | 0.677 |
| Significance level | 0.0792 | 0.0949 | |
| age 85-on | Correlation coefficient | 0.462 | 0.442 |
| Significance level | 0.2966 | 0.3208 | |
| No. >45 | Correlation coefficient | 0.747 | 0.730 |
| Significance level | 0.0535 | 0.0623 | |
| No. 15–44 | Correlation coefficient | 0.291 | 0.334 |
| Significance level | 0.5262 | 0.4636 | |
| Correlation coefficient | |||
| Significance level | |||
| Correlation coefficient | |||
| Significance level | |||
| Correlation coefficient | |||
| Significance level | |||
Statistically significant, with p-value <0.05.
Pearson׳s correlation between GT-based data and clinical symptoms/diseases associated with silicosis.
| Lung cancer | Correlation coefficient | 0.714 | 0.740 |
| Significance level | 0.0712 | 0.0574 | |
| Laryngeal cancer | Correlation coefficient | −0.749 | −0.786 |
| Significance level | 0.0526 | 0.0360 | |
| Rheumatoid arthritis | Correlation coefficient | ||
| Significance level | |||
| Systemic Lupus Erythematosus | Correlation coefficient | ||
| Significance level | |||
| Scleroderma | Correlation coefficient | ||
| Significance level | |||
| Tubercolosis | Correlation coefficient | 0.083 | 0.106 |
| Significance level | 0.8588 | 0.8217 | |
| Anorexia | Correlation coefficient | 0.220 | 0.184 |
| Significance level | 0.6348 | 0.6931 | |
| Cough | Correlation coefficient | −0.740 | |
| Significance level | 0.0571 | ||
| Dyspnea | Correlation coefficient | −0.725 | |
| Significance level | 0.0654 | ||
| Fatigue | Correlation coefficient | −0.576 | −0.612 |
| Significance level | 0.1756 | 0.1438 | |
| Fever | Correlation coefficient | ||
| Significance level | |||
| Respiratory failure | Correlation coefficient | ||
| Significance level | |||
| Tachipnea | Correlation coefficient | ||
| Significance level | |||
Statistically significant, with p-value <0.05;
Statistically significant, with p-value <0.01.
Pearson׳s correlation between GT-based data concerning clinical symptoms/diseases associated with silicosis and silicosis epidemiological data (namely, death rate and number of deaths) in the study period 2004–2010.
| Lung cancer | Correlation coefficient | 0.736 | 0.697 |
| Significance level | 0.0595 | 0.0818 | |
| Laryngeal cancer | Correlation coefficient | −0.680 | −0.628 |
| Significance level | 0.0929 | 0.1308 | |
| Rheumatoid arthritis | Correlation coefficient | 0.476 | 0.445 |
| Significance level | 0.2797 | 0.3165 | |
| Systemic Lupus Erythematosus | Correlation coefficient | 0.455 | 0.399 |
| Significance level | 0.3051 | 0.3755 | |
| Scleroderma | Correlation coefficient | ||
| Significance level | |||
| Tubercolosis | Correlation coefficient | −0.007 | −0.030 |
| Significance level | 0.9879 | 0.9484 | |
| Anorexia | Correlation coefficient | −0.161 | −0.175 |
| Significance level | 0.7299 | 0.7080 | |
| Cough | Correlation coefficient | ||
| Significance level | |||
| Dyspnea | Correlation coefficient | ||
| Significance level | |||
| Fatigue | Correlation coefficient | −0.753 | −0.729 |
| Significance level | 0.0505 | 0.0632 | |
| Fever | Correlation coefficient | ||
| Significance level | |||
| Respiratory failure | Correlation coefficient | ||
| Significance level | |||
| Tachipnea | Correlation coefficient | ||
| Significance level | |||
Statistically significant, with p-value <0.05;
Statistically significant, with p-value <0.01.
| Subject area | |
|---|---|
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | USA |
| Data accessibility | Data are within this article |